Skip to content
Use caution Drug recall · FDA · Published April 4, 2014

Roxanne Labs Recalls Azathioprine Tablets Due to Labeling Errors

Roxanne Laboratories recalls 8,304 bottles of Azathioprine 50mg tablets because labels show incorrect expiration dates. Check your lot number.

🇺🇸 FDA recall #D-1313-2014DrugRoxanne Laboratories ›
Take action

Contact the company

Recalling firmBoehringer Ingelheim Roxane Inc1809 Wilson Rd · Columbus, OH 43228-9579
✎ GovInfoNow plain-language explainer

Roxanne Laboratories is recalling 8,304 bottles of Azathioprine Tablets USP, 50 mg because the packaging displays an incorrect expiration date. The product was labeled with a 36-month expiration period instead of the approved 24 months. This affects Lot 261983A distributed nationwide. Read more at govinfonow.com/recall/46150-boehringer-ingelheim-roxane-inc-recalls-azathioprine-tablets-usp-50-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/46150-boehringer-ingelheim-roxane-inc-recalls-azathioprine-tablets-usp-50-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-1313-2014

Cite this page

“Roxanne Labs Recalls Azathioprine Tablets Due to Labeling Errors.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46150-boehringer-ingelheim-roxane-inc-recalls-azathioprine-tablets-usp-50-mg. Based on FDA recall #D-1313-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1313-2014%22&limit=1).

The FDA announced on April 4, 2014, that Boehringer Ingelheim Roxane Inc voluntarily recalled Azathioprine Tablets USP, 50 mg, due to labeling errors where expiration dates were incorrectly set to 36 months instead of the filed 24 months. The agency said the recall affects 8,304 bottles distributed nationwide.

How to tell if you have it

  • Brand: Roxanne Laboratories
  • Product: Azathioprine Tablets USP 50 mg
  • Packaging: 100 count bottle
  • NDC: 0054-4084-25
  • Lot code: 261983A
  • Incorrect expiration date shown: 11/15

The hazard

The recall is due to incorrect or missing lot and expiration dates on the label. The product was given 36-month expiration dates instead of the filed 24 months, according to the FDA.

Context

GovInfoNow's records show Boehringer Ingelheim Roxane Inc has had 12 other recalls since November 5, 2012. Recent brand recalls include a September 25, 2015 recall of FUROSEMIDE Tablets USP due to CGMP deviations and an April 2, 2015 recall of Acarbose 50mg Tablets for low potency. Other recent recalls of similar products include OurPharma Fentanyl Injection Recall (September 3, 2026), American Regent Levocarnitine Injection Recall (April 16, 2026), and Ajanta Pharma Recalls Ranolazine 1000mg (September 17, 2026).

How to tell if you have this one

Look for a 100-count bottle of Azathioprine Tablets USP, 50 mg manufactured by Roxanne Laboratories. Check the NDC number 0054-4084-25 and specifically verify if the lot number is 261983A.

  • Brand
    Roxanne Laboratories
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide
Recall numberProduct, codes & lotsQuantityNDC
D-1313-2014Azathioprine Tablets USP, 50 mg, 100 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216, NDC 0054-4084-25; Lot 261983A Exp.11/158,304 bottles—
D-1314-2014Mercaptopurine Tablets USP, 50 mg, 25 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216, NDC 0054-4581-11; Lot 261997A Exp 02/16; 262214V, 359283V Exp. 05/1698,560 bottles0054-4581-27, 0054-4581-11
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your medication matches the recalled NDC 0054-4084-25 and Lot 261983A.

  2. Contact Your Pharmacist

    Speak with your healthcare provider or pharmacist to determine if you have the affected product and what steps to take next.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Apr 4, 201412. FDA classified it Class III: May 6, 201423. Published in FDA’s Enforcement Report: May 14, 201434. FDA terminated the recall: Apr 1, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1313-2014 (April 4, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1313-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA